Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears competing views on kratom; bill left in study form as stakeholders seek regulatory approach
Summary
Lawmakers heard extensive testimony from users, industry groups and state health officials about kratom and left House Bill 1566 in study form to allow further work on an appropriate regulatory framework.
The Senate Energy and Natural Resources Committee heard hours of testimony on House Bill 1566, a proposal to create a regulatory framework for kratom products in North Dakota, but did not advance the bill; lawmakers left it in study form to allow further review and stakeholder work.
Sponsor testimony said the impetus for the bill came after a bill to schedule kratom as a controlled substance produced mixed evidence in another committee. Representative Dan Johnson (District 24) told senators that consumers, parts of the industry and some law enforcement have asked for…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
